MIRA INFORM REPORT

 

 

Report Date :

03.10.2013

 

IDENTIFICATION DETAILS

 

Name :

PHARMACARE EGYPT FOR TRADING AGENCY

 

 

Registered Office :

989 Corniche El Nile Street, El Malek Al Saleh, El Manial, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

27.03.2000

 

 

Com. Reg. No.:

43545, Cairo

 

 

Legal Form :

Sole Proprietorship

 

 

Line of Business :

manufacturer of pharmaceuticals, cosmetics and beauty products.

 

 

No. of Employees :

120

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

No Complaints 

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Egypt

B1

B1

 

Risk Category

ECGC Classification

 

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

egypt ECONOMIC OVERVIEW

 

Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government backtracked on economic reforms, drastically increasing social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction were among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow during the next several years. The government drew down foreign exchange reserves by more than 50% in 2011 and 2012 to support the Egyptian pound and the dearth of foreign financial assistance - as a result of unsuccessful negotiations with the International Monetary Fund over a multi-billion dollar loan agreement which have dragged on more than 20 months - could precipitate fiscal and balance of payments crises in 2013.

 

Source : CIA

 

 

 

 

SUMMARY

 

Company Name                                    : PHARMACARE EGYPT FOR TRADING AGENCY

Country of Origin                                   : Egypt

Legal Form                                           : Sole Proprietorship

Registration Date                                  : 27th March 2000

Commercial Registration Number           : 43545, Cairo

Tax Card Number                                  : 210-237-945

Invested Capital                                    : £E 5,000,000

Total Workforce                                     : 120

Activities                                               : Manufacturers of pharmaceuticals, cosmetics and beauty products.

Financial Condition                                : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                    : Steady

COMPANY NAME

 

PHARMACARE EGYPT FOR TRADING AGENCY

 

 

company ADDRESS

 

Registered & Physical Address

Street               : 989 Corniche El Nile Street

Area                 : El Malek Al Saleh, El Manial

Town                : Cairo

Country             : Egypt

 

Telephone         : (20-2) 23649485 / 23680019

Facsimile          : (20-2) 25322177

Mobile              : (20-12) 9776118

Email                : pharmacare@link.net / dr.hamdy_pharmacare@yahoo.com

 

Premises

Subject operates from a large suite of offices and a factory that are rented and located in the Industrial Area of Cairo.

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Dr Ossama Sayed Antar                                                                   Proprietor

 

·       Dr Hamdy El Gebeley                                                                       Marketing Manager

 

·       Dr Ashraf Hanafy                                                                              Commercial Manager

 

·       Al Jameel Antar                                                                                Finance Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 27th March 2000

 

Legal Form                  : Sole Proprietorship

 

Commercial Reg. No.   : 43545, Cairo

 

Tax Card No.                : 210-237-945

 

Invested Capital           : £E 5,000,000

 

Dr. Ossama Sayed Antar is the sole proprietor of the business.

 

 

AFFILIATED COMPANIES

 

·       Ago Exim Pvt Ltd

233 Swastik Plaza

Subhash Nagar

Pokhran Road No. 2

Thane 400606

India

Tel: (91-22) 21731583 / 21717273

 

·       Multi Care

989 Corniche El Nile Street

El Malek El Saleh

El Manial

Cairo

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of pharmaceuticals, cosmetics and beauty products.

 

Import Countries: India, Greece, New Zealand and the United States of America.

 

International Suppliers:

 

·       Belcare                    India

·       Proel                        Greece

·       Natural Life               New Zealand

·       RX Vitamins            United States of America

 

Export Countries: Saudi Arabia

 

Operating Trend: Steady

 

Subject has a workforce of 120 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pound (£E) 

 

                                                Year Ending 31/12/11:               Year Ending 31/12/12:

 

Total Sales                                £E 62,700,000                           £E 64,460,000

 

Local sources consider subject’s financial condition to be Good.

 

The above financial figures are based on estimations by our local sources.

 

 

BANKERS

 

·       Commercial International Bank (CIB)

Nile Tower Building

21-23 Giza Street

PO Box: 2430

Cairo

Tel: (20-2) 25703043

Fax: (20-2) 25703172 / 25072691

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the business is considered to be a fair trade risk.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.62.36

UK Pound

1

Rs.101.20

Euro

1

Rs.84.54

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.